Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis.
Atzeni IM, Al-Adwi Y, Doornbos-van der Meer B, Roozendaal C, Stel A, van Goor H, Gan CT, Dickinson M, Timens W, Smit AJ, Westra J, Mulder DJ. Atzeni IM, et al. Among authors: mulder dj. Front Immunol. 2023 Jun 20;14:1189257. doi: 10.3389/fimmu.2023.1189257. eCollection 2023. Front Immunol. 2023. PMID: 37409127 Free PMC article.
Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
Bourgonje AR, Abdulle AE, Bourgonje MF, Kieneker LM, la Bastide-van Gemert S, Gordijn SJ, Hidden C, Nilsen T, Gansevoort RT, Mulder DJ, Dullaart RPF, de Borst MH, Bakker SJL, van Goor H. Bourgonje AR, et al. Among authors: mulder dj. Biomolecules. 2023 Feb 9;13(2):338. doi: 10.3390/biom13020338. Biomolecules. 2023. PMID: 36830706 Free PMC article.
High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y, Atzeni IM, Doornbos-van der Meer B, van der Leij MJ, Varkevisser RDM, Kroesen BJ, Stel A, Timens W, Gan CT, van Goor H, Westra J, Mulder DJ. Al-Adwi Y, et al. Among authors: mulder dj. EBioMedicine. 2023 Dec;98:104883. doi: 10.1016/j.ebiom.2023.104883. Epub 2023 Nov 22. EBioMedicine. 2023. PMID: 37995465 Free PMC article.
A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General Population.
Bourgonje AR, Bourgonje MF, la Bastide-van Gemert S, Nilsen T, Hidden C, Gansevoort RT, Mulder DJ, Hillebrands JL, Bakker SJL, Dullaart RPF, van Goor H, Abdulle AE. Bourgonje AR, et al. Among authors: mulder dj. Kidney Int Rep. 2024 Feb 16;9(5):1265-1275. doi: 10.1016/j.ekir.2024.02.1392. eCollection 2024 May. Kidney Int Rep. 2024. PMID: 38707832 Free PMC article.
Severely increased albuminuria in patients with type 2 diabetes mellitus is associated with increased subclinical atherosclerosis in femoral arteries with Na [18F]F activity as a proxy - The DETERMINE study.
Reijrink M, Sluiter JKE, Te Velde-Keyzer CA, de Borst MH, van Praagh GD, Greuter MJW, Luurtsema G, Boersma HH, Pol RA, Hillebrands JL, van Dijk PR, Hoogenberg K, Mulder DJ, Slart RHJA. Reijrink M, et al. Among authors: mulder dj. Atherosclerosis. 2023 Jul 29:117199. doi: 10.1016/j.atherosclerosis.2023.117199. Online ahead of print. Atherosclerosis. 2023. PMID: 37550141 Free article.
Effect of vitamin K supplementation on serum calcification propensity and arterial stiffness in vitamin K-deficient kidney transplant recipients: A double-blind, randomized, placebo-controlled clinical trial.
Eelderink C, Kremer D, Riphagen IJ, Knobbe TJ, Schurgers LJ, Pasch A, Mulder DJ, Corpeleijn E, Navis G, Bakker SJL, de Borst MH, Te Velde-Keyzer CA. Eelderink C, et al. Among authors: mulder dj. Am J Transplant. 2023 Apr;23(4):520-530. doi: 10.1016/j.ajt.2022.12.015. Epub 2023 Jan 3. Am J Transplant. 2023. PMID: 36695702 Free article. Clinical Trial.
LOFIT (Lifestyle front Office For Integrating lifestyle medicine in the Treatment of patients): a novel care model towards community-based options for lifestyle change-study protocol.
van Dijk ML, Te Loo LM, Vrijsen J, van den Akker-Scheek I, Westerveld S, Annema M, van Beek A, van den Berg J, Boerboom AL, Bouma A, de Bruijne M, Crasborn J, van Dongen JM, Driessen A, Eijkelenkamp K, Goelema N, Holla J, de Jong J, de Joode A, Kievit A, Klooster JV, Kruizenga H, van der Leeden M, Linders L, Marks-Vieveen J, Mulder DJ, Muller F, van Nassau F, Nauta J, Oostvogels S, Oude Sogtoen J, van der Ploeg HP, Rijnbeek P, Schouten L, Schuling R, Serné EH, Smuling S, Soeters MR, Verhagen EALM, Zwerver J, Dekker R, van Mechelen W, Jelsma JGM. van Dijk ML, et al. Among authors: mulder dj. Trials. 2023 Feb 17;24(1):114. doi: 10.1186/s13063-022-06960-z. Trials. 2023. PMID: 36803271 Free PMC article.
139 results